Fate Therapeutics (FATE)
(Delayed Data from NSDQ)
$4.06 USD
-0.04 (-0.98%)
Updated May 3, 2024 04:00 PM ET
After-Market: $4.05 -0.01 (-0.25%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/08/2024
Time: -- |
3/2024 | $-0.48 | 0.00% |
Earnings Summary
For their last quarter, Fate Therapeutics (FATE) reported earnings of -$0.45 per share, beating the Zacks Consensus Estimate of $-0.57 per share. This reflects a positive earnings surprise of 21.05%. Look out for FATE's next earnings release expected on May 08, 2024. For the next earning release, we expect the company to report earnings of -$0.48 per share, reflecting a year-over-year decrease of 152.63%.
Earnings History
Price & Consensus
Zacks News for FATE
Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
FATE: What are Zacks experts saying now?
Zacks Private Portfolio Services